A recent study showed that inhibition of PI3K or AKT1 reduces the frequency of BTIC-enriched CD44High/CD24Low breast tumor cells by initiating their apoptosis via FOXO3a and Bim [45]. The gene discussed is BCL2L11; the disease is breast neoplasm.